☃️ On the 1st day of #Photonmas, we celebrate having reached 🌟 1 million 🌟 prescriptions routed. We like to see it as 1 million opportunities for Photon to help patients fulfill their medications with greater ease and transparency (or perhaps: 1 million headaches saved 😄). Stay tuned as we count the days of #Photonmas and celebrate an eventful year. #DigitalHealth #HealthcareStartup #PharmacyInnovation #PatientExperience
Photon’s Post
More Relevant Posts
-
Patient preference is a key factor when prescribing medication. Some patients want the convenience of a daily pill. Others favour only having to deal with meds every couple of months via infusions. Or for many it’s the convenience of “jab and go” injections done at home. I’ve put together this table of Crohn’s and UC medications by administration route. Hopefully a handy guide for IBD patients, and an aide memoire for prescribers - UK only. #ibd #inflammatoryboweldisease #crohns #crohnsdisease #ulcerativecolitis #guthealth #patientcentredcare
To view or add a comment, sign in
-
Join us tonight for the VECCS x VIN Webinar with Marcia Fletcher! Learn about anesthetizing compromised patients, preparation, stabilization methods, and more. Check your member emails for details!
To view or add a comment, sign in
-
World Anticoagulated Patient Day raises awareness about the challenges faced by patients on anticoagulant therapy. It promotes education on managing anticoagulation safely, highlights the importance of regular monitoring, and supports patients in leading healthy lives. This day encourages global efforts to improve care and support for these patients. #AnticoagulatedPatientDay, #BloodThinners, #PatientAwareness, #HealthEducation, #SafeManagement, #RegularMonitoring, #PatientSupport
To view or add a comment, sign in
-
Did you know that there is a target range for dosing patients with VNS Therapy™? Only 6.3% of patients responded to output current and pulse width below the minimum target range. And 57.5% of responders had output current and pulse width within the target range. Reaching the target range for dosing within 3 months according to the recommended protocol results in a faster onset of response for many patients. Discover the target range here: https://bit.ly/3jKgAGC To learn more about VNS Therapy visit: https://bit.ly/3O15BlD Important safety information: https://bit.ly/3cdsPrp #vnstherapy #epilepsy #wearelivanova
To view or add a comment, sign in
-
Many Americans use prescription pain medication to ease pain. Pain can be relentless and overwhelming. But why do many people rely only on prescriptions to manage pain? While doctor-prescribed pain medications work in some cases, they only mask the pain without resolving the root cause. Sumner PTs and PTAs treat pain through movement, hands-on therapy, and patient education—without the warning labels! To learn more about how we can help YOU, visit #PhysicalTherapyMonth
To view or add a comment, sign in
-
Did you know that there is a target range for dosing patients with VNS Therapy™? Only 6.3% of patients responded to output current and pulse width below the minimum target range. And 57.5% of responders had output current and pulse width within the target range. Reaching the target range for dosing within 3 months according to the recommended protocol results in a faster onset of response for many patients. Discover the target range here: https://bit.ly/3jKgAGC To learn more about VNS Therapy visit: https://bit.ly/3O15BlD Important safety information: https://bit.ly/3cdsPrp #vnstherapy #epilepsy #wearelivanova
To view or add a comment, sign in
-
Did you know that there is a target range for dosing patients with VNS Therapy™? Only 6.3% of patients responded to output current and pulse width below the minimum target range. And 57.5% of responders had output current and pulse width within the target range. Reaching the target range for dosing within 3 months according to the recommended protocol results in a faster onset of response for many patients. Discover the target range here: https://bit.ly/3jKgAGC To learn more about VNS Therapy visit: https://bit.ly/3O15BlD Important safety information: https://bit.ly/3cdsPrp #vnstherapy #epilepsy #wearelivanova
To view or add a comment, sign in
-
Keeping rancid materials out of the feeding lumen while cleaning the ENFit connector is essential. #patientsafety, #Enfit, #gedsa, #oley, #enclean
Enhance the standard of care for enteral patients with ENFit connectors. #synova, #oley, #enfit, #tubi, #patientsafety, #enclean
To view or add a comment, sign in
-
Did you know that there is a target range for dosing patients with VNS Therapy™? Only 6.3% of patients responded to output current and pulse width below the minimum target range. And 57.5% of responders had output current and pulse width within the target range. Reaching the target range for dosing within 3 months according to the recommended protocol results in a faster onset of response for many patients. Discover the target range here: https://bit.ly/3jKgAGC To learn more about VNS Therapy visit: https://bit.ly/3O15BlD Important safety information: https://bit.ly/3cdsPrp #vnstherapy #epilepsy #wearelivanova
To view or add a comment, sign in
-
REAPPLIX PRIVATE CIRCLE FOR DIABETIC FOOT ULCERS Reapplix, an international wound care company, has recently launched a RegenMed Private Circle aggregating clinical and long-term outcomes data on its personalized diabetic foot ulcer product. The diabetic foot ulcer market value is estimated at $5.2 billion. About 60% of all patients experience a wound that does not heal. If the severity of a wound progresses to grade 4 or 5, the cost of treatment is eight times higher than a grade 1 or 2 wound. For about 20% of patients, treatment ends in amputation within one year. The Reapplix Circle will help the company, its clinical customers, and their patients further support the safety and efficacy of its products. For more information on this Circle, including applying to join, see here: https://lnkd.in/evVcz8ch #collaboration #realworlddata #valuebasedcare
To view or add a comment, sign in
2,629 followers